| Literature DB >> 30808286 |
Sara de Las Heras-Saldana1, Ki Yong Chung2, Seung Hwan Lee3, Cedric Gondro4.
Abstract
BACKGROUND: Korean Hanwoo cattle are known for their high meat quality, especially their high intramuscular fat compared to most other cattle breeds. Different muscles have very different meat quality traits and a study of the myogenic process in satellite cells can help us better understand the genes and pathways that regulate this process and how muscles differentiate.Entities:
Keywords: Hanwoo; Muscle differentiation; Myogenesis; RNA-seq; Satellite cell
Mesh:
Year: 2019 PMID: 30808286 PMCID: PMC6390542 DOI: 10.1186/s12864-019-5530-7
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Phase contrast and immunohistochemistry of MSC during differentiation in bovine LD and SM tissues on days 0, 1, 4 and 7
Fig. 2Differentiation indexes (area occupied by myotubes) on days 3, 4 and 7 in SM and LD
Summary of RNA-seq reads
| Muscle | Day | Total reads | Clean reads | Mapped reads |
|---|---|---|---|---|
| LD | 0 | 64,653,898.67 | 32,326,949.33 | 82% |
| 1 | 84,792,260 | 42,396,130 | 80% | |
| 2 | 83,802,156.67 | 41,901,078.33 | 80% | |
| 4 | 77,402,347.33 | 33,542,207.33 | 80% | |
| 7 | 59,158,033.33 | 29,579,016.67 | 80% | |
| 14 | 59,413,041.33 | 29,706,520.67 | 80% | |
| SM | 0 | 68,553,754.67 | 34,276,877.33 | 83% |
| 1 | 80,691,319.33 | 40,657,234 | 80% | |
| 2 | 83,065,964.67 | 41,532,982.33 | 81% | |
| 4 | 79,723,010 | 39,861,505 | 82% | |
| 7 | 62,983,208.67 | 31,491,604.33 | 81% | |
| 14 | 62,921,703.33 | 31,460,851.67 | 81% |
The values presented are the average of the three biological replicates for each muscle and time point
Fig. 3Expression of Myogenic Regulatory Factors and transcription factors in LD (blue lines) and SM (red lines) detected by qPCR. Error bars show standard errors of the mean of three biological replicates for three technical replicates
Fig. 4Venn diagram with the number of common DE genes (FDR < 0.05, abs(log2FC) ≥2) between contrast of each timepoint vs day 0 for LD and SM muscles
Fig. 5Expression profile of DE genes comparing RNA-seq (solid bars) and qPCR (checkered bars) results during differentiation of satellite cells from LD (blue bars) and SM (red bars) muscles. The R2 Pearson correlation is shown for each gene
List of qPCR primers used to validate the expression results from the RNA-seq analysis
| Gene | Sequence (5′-3′) |
|---|---|
| RPS9 | |
| Myogenin | |
| Myo D | |
| Myf 5 | |
| MYF6 | |
| IGF1 | |
| PAX3 | |
| HOXC11 | |
| SIM2 | |
| HOXC8 | |
| HOXB9 | |
| ZIC2 | |
| ZIC4 | |
| TBX4 | |
| HOXB4 | |
Gene Ontology of the differentially expressed genes in LD and SM muscles for days 1, 7 and 14 in relation to day 0. MF: molecular function; CC: cellular components; BP: biological process. Number of DE genes that are up-regulated (↑) and down-regulated (↓)
| Day 1 | Day 7 | Day 14 | |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| MF | Calcium ion binding | ↓19 | Cytoskeletal protein binding | ↑7↓8 | Receptor activity | ↑15↓2 |
| Transmembrane receptor activity | ↓15 | Double-stranded DNA binding | ↑4↓6 | Cytoskeletal protein binding | ↑9↓8 | ||
| Hormone activity | ↑1↓7 | Microtubule binding | ↓7 | Protein kinase binding | ↑6↓5 | ||
| Peptidase inhibitor activity | ↑4↓2 | ||||||
| CC | Extracellular space | ↑ 4↓31 | Cytoskeletal part | ↑5↓20 | Cytoskeletal part | ↑7↓16 | |
| Myofibril | ↓25 | Myofibril | ↑12 | Myofibril | ↑13 | ||
| Sarcomere | ↓22 | Microtubule | ↑12 | Sarcomere | ↑12 | ||
| Actin cytoskeleton | ↓17 | Sarcomere | ↑11 | Microtubule organizing center | ↑1↓11 | ||
| I band | ↓13 | I band | ↑7 | I band | ↑6 | ||
| BP | Regulation of multicellular organismal process | ↑1↓37 | Cell cycle | ↑1↓33 | Cell cycle | ↑3↓29 | |
| Immune system process | ↑1↓27 | Cytoskeleton organization | ↑5↓15 | Phosphorylation | ↑13↓15 | ||
| Muscle structure development | ↓17 | Protein phosphorylation | ↑6↓13 | Cell proliferation | ↑9↓16 | ||
| Actin filament-based process | ↓14 | Cell proliferation | ↑5↓13 | Muscle structure development | ↑13↓3 | ||
| Muscle cell differentiation | ↓11 | Microtubule-based process | ↓15 | Negative regulation of proteolysis | ↑6↓4 | ||
|
| MF | Cytoskeletal protein binding | ↑12↓10 | Receptor binding | ↑15↓16 | ||
| Peptidase inhibitor activity | ↑5↓4 | Receptor activity | ↑27↓3 | ||||
| Protease binding | ↑4↓2 | Cytoskeletal protein binding | ↑17↓12 | ||||
| Peptidase inhibitor activity | ↑7↓3 | ||||||
| CC | Contractile fiber | ↓10 | Cytoskeletal part | ↑23↓13 | Extracellular space | ↑34↓13 | |
| Sarcomere | ↓9 | Extracellular space | ↑24↓9 | Cytoskeletal part | ↑18↓24 | ||
| Myofibril | ↓9 | Myofibril | ↑20 | Myofibril | ↑23↓1 | ||
| Actin cytoskeleton | ↓9 | Sarcomere | ↑18 | Sarcomere | ↑21↓1 | ||
| I band | ↓5 | Microtubule | ↑1↓12 | I band | ↑12 | ||
| BP | Muscle structure development | ↓7 | Cell cycle | ↑5↓34 | Immune system process | ↑36↓10 | |
| Regulation of muscle system process | ↓5 | Cytoskeleton organization | ↑10↓16 | Cell cycle | ↑6↓36 | ||
| Striated muscle tissue development | ↓5 | Inflammatory response | ↑12↓3 | Cell proliferation | ↑15↓23 | ||
| Regulation of muscle contraction | ↓4 | Muscle organ development | ↑12 | Cytoskeleton organization | ↑16↓18 | ||
| G2/M transition of mitotic cell cycle | ↑1↓4 | Muscle structure development | ↑21↓5 | ||||
Fig. 6Differentially expressed genes involved in the GO term G2/M transition of mitotic cell cycle for a) LD and b) SM